Why AIIR CoLab Can Lead Co-Creation in Oral Delivery Systems

Strength, Science, and a Global R&D Ecosystem Led by AIIR

The future of oral delivery systems—whether nicotine pouches, fast-dissolving oral strips, plant–based actives, or functional formulations—will be shaped by companies that can combine scientific depth, cross-disciplinary innovation, and scalable manufacturing. AIIR CoLab was created with this vision in mind.

AIIR CoLab is not simply a platform. It is a scientific ecosystem led by AIIR and empowered by a global research network spanning biotechnology, flavor science, analytical chemistry, materials engineering, and product formulation. Through this networked model, AIIR is able to accelerate discovery, conduct highly specialized experiments, validate results through certified laboratories, and convert innovations into commercializable oral delivery solutions.

In this article, we explain why AIIR is uniquely positioned to lead co-creation in the next generation of oral delivery systems, and how AIIR CoLab integrates science, technology, and manufacturing to enable a new era of collaborative innovation.

1. AIIR’s R&D Vision: A Full-Stack Scientific Ecosystem

AIIR’s research philosophy is rooted in technology-driven development, with the goal of building a complete innovation chain—from biological pathways and lab-scale experiments to pilot-scale trials and full industrialization.

Core Principles Behind AIIR’s R&D Strategy

• Science-first development: From gene/cell engineering to advanced analytics and formulation science.
• High-caliber research team: More than 55% of AIIR’s workforce is R&D, including PhD-level scientists, postdoctoral researchers, and senior engineers.
• Long-term research alliances: AIIR works with joint innovation labs, academic partners, and specialized institutes through multi-year programs and co-development frameworks.
• Sustained R&D investment: Over 30% of annual profit is consistently reinvested into research platforms, analytical capabilities, materials science, and product development.

This structure—AIIR internal expertise + AIIR-led extended research network—gives the company a level of scientific coverage that very few NGP or oral-delivery companies possess.

2. Multi-Platform R&D Capabilities: The Engine Behind CoLab

AIIR’s R&D capabilities are built across multiple specialized platforms. Each platform contributes a different scientific dimension to AIIR CoLab, forming a unified ecosystem for innovation.

2.1 Synthetic Biology & Microbial Cell Factory Platform

AIIR leads innovation in biomanufacturing through a robust synthetic biology and metabolic engineering platform capable of:

• Constructing microbial cell factories for rare natural molecules
• Producing natural aroma compounds such as coumarin, vanillin, phenols, terpenes, and benzenoids
• Establishing and maintaining a library of 500+ aroma-producing microbial strains
• Conducting strain optimization, fermentation engineering, and purification
• Scaling production from lab (10 L) to pilot scale (500 L) to industrial scale (10-ton lines)

These capabilities allow AIIR CoLab to explore natural aroma components, create bio-derived actives, and design natural sensory systems for next-generation oral products.

2.2 Natural Extraction & Separation Platform

To complement bio-manufacturing, AIIR’s extraction platform uses supercritical CO₂ extraction, molecular distillation, and high-efficiency low-temperature separation, enabling:

• Up to 40% improvement in the yield of heat-sensitive compounds
• High-purity natural extracts suitable for oral pouches and strips
• Fermentation-enhanced aroma materials
• Plant-based functional actives

The combination of biotechnology and advanced extraction provides an unparalleled natural-materials pipeline.

2.3 CNAS-Certified Analytical Laboratory & Quality Systems

AIIR operates a CNAS-certified analytical center aligned with ISO/IEC 17025, equipped with advanced instrumentation:

• GC-MS
• LC-MS
• ICP-MS
• Smoke machine analysis
• Atomic absorption and fluorescence spectroscopy

The center supports more than 20+ analytical parameters and maintains:

• Natural raw-material spectral database
• Aroma compound MS library
• Flavor and sensory reference library

This enables AIIR CoLab partners to validate formulations, quantify actives, and ensure regulatory-grade product consistency.

2.4 AI-Driven R&D and Digital Manufacturing

AIIR integrates AI, machine learning, and Industry 4.0 to convert scientific insights into manufacturable products.

Key digital capabilities include:

• AI-driven formula generator using global ingredient databases and sensory models
• Environmental adaptation models predicting ingredient stability
• Heat simulation algorithms for flavor performance
• MES/ERP/MOM/BI systems enabling full traceability and intelligent production
• Blockchain-enabled supply chain transparency
• Flexible production lines supporting small-batch customization

Artificial intelligence is central to how AIIR CoLab accelerates experimentation and improves prediction accuracy for oral delivery systems.

2.5 Materials Science, Carriers & Oral Delivery Technologies

AIIR’s materials and formulation platforms focus on inventing the carriers and matrices that deliver actives safely, efficiently, and with controlled release.

Capabilities include:

• Microencapsulation
• Controlled-release granules
• Dual-embedding particles
• Nano-emulsions
• Fast-dissolving ODF (oral dissolving films)
• Oral capsules (rupture-type and dissolvable-type)
• Stabilization of volatile actives
• Sensory performance optimization

These technologies are directly applicable to nicotine strips, functional oral films, pouches, and hybrid oral-delivery formats.

3. A Distributed R&D Network Led by AIIR

AIIR’s research ecosystem spans multiple cities and specialty centers, forming a distributed yet integrated scientific network.

AIIR’s Core R&D Locations

• Shenzhen Headquarters & CNAS Analysis Center
  Focus: Natural active-compound R&D, advanced analytics, regulatory-grade testing.
• Shanghai Laboratory
  Focus: Microbial biosynthesis, metabolic engineering, and natural aroma bioproduction.
• Yunnan Laboratory
  Focus: Natural aromatic plants, material resource development, extraction optimization.
• Hubei Laboratory
  Focus: Tobacco flavors, new materials, and plant-derived compounds.
• Dongguan Laboratory & Scale-Up Base
  Focus: Large-scale flavor production, application development, industrial integration.

Each center operates with AIIR’s scientific direction, coordinated through unified digital systems, centralized data platforms, and shared quality frameworks.

This structure enables AIIR CoLab to:

• Access specialized research capabilities
• Conduct parallel experiments
• Scale successful formulas to industrial production
• Ensure consistent quality across all nodes

4. Scientific Achievements & Breakthrough Technologies

AIIR’s technological strengths translate into concrete R&D outputs, including:

• Industrial-scale biosynthesis of rare natural molecules
• 40% better extraction efficiency for heat-sensitive actives
• Industry-first natural aroma MS spectral library
• AI-powered formulation system linking raw materials to sensory outcomes
• Next-generation oral delivery carriers including nano-emulsions, microcapsules, controlled-release granules, and ODF films
• Full CNAS laboratory testing for vapor, aerosol, and oral-delivery product safety
• Integration of biotechnology + materials science + digital manufacturing

These achievements form the scientific backbone of AIIR CoLab.

5. Co-Creation, Commercialization & Global Partnerships

AIIR’s co-creation model is rooted in industry–academia–research synergy, enabled through:

• Joint innovation labs
• Partner research institutes
• Academic collaboration frameworks
• High-level talent programs and postdoctoral research bases

AIIR also maintains a clear technology-transfer path:

Lab R&D → Pilot Scale (10 L → 500 L → 10T) → GMP/Industrial Production → Global Commercialization

This process is supported by production capabilities across:

• Hubei
• Jiangxi
• Indonesia
• Additional GMP/CGMP compliant facilities

AIIR works with domestic and international partners, including global FMCG, tobacco, and functional-product companies.

Coupled with strong IP systems—covering risk control, PCT portfolios, and international patent layouts—AIIR ensures global competitiveness and long-term platform stability.

6. Why AIIR CoLab Can Lead the Future of Oral Delivery Systems

Putting all these capabilities together, the answer becomes clear:

AIIR CoLab is rooted in scientific depth, cross-disciplinary capability, and industrial execution.

It excels because AIIR provides:

✔ A complete end-to-end R&D ecosystem

Raw materials → Synthetic biology → Extraction → Analytical chemistry → Formulation → Materials science → Pilot → GMP production.

✔ A distributed research network led and coordinated by AIIR

Multiple labs + digital integration = expanded scientific coverage with consistent direction.

✔ Advanced oral-delivery technologies

ODF films, nano-emulsions, controlled release systems, microencapsulation, and more.

✔ AI + data-driven formulation

Accelerated discovery and predictable sensory performance.

✔ Certified analytical credibility

CNAS laboratory ensuring compliance and validation.

✔ Industrial scale-up and global commercialization

From research to mass production to regulatory-grade quality systems.

✔ A platform built for collaboration

By integrating experts in bioscience, sensory science, material science, flavor chemistry, and product engineering.

Together, this makes AIIR CoLab one of the most capable co-creation platforms in the oral delivery sector.

7. Co-Creating the Future of Oral Delivery

AIIR CoLab invites:

• Oral-delivery innovators
• Food and flavor scientists
• Biotech researchers
• Functional product developers
• Brands seeking new sensory systems
• Formulation experts and materials engineers

to join a scientific ecosystem that is open, collaborative, and designed for real-world impact.

The future of oral delivery will not be built in isolation.
It will be co-created—through science, technology, and shared knowledge.

AIIR CoLab is ready to lead that future.